Auspex Pharmaceuticals' Series E Round

Auspex Pharmaceuticals raised a round of funding on January 08, 2014.

Auspex Pharmaceuticals is a privately held biopharmaceutical company focused on the use of deuterium in medicinal chemistry, and the treatment of hyperkinetic movement disorders including Huntington's…

Articles about Auspex Pharmaceuticals' Series E Round: